Sight Sciences, Inc. has grown revenue 0.76% a year over three years and 17% a year over five. Revenue growth, 3-year annual rate: +0.76% (Medical Devices median +12%). Revenue growth, 5-year rate: +17%, growth has slowed since the five-year average. Years of annual history on file: 6, FY2020 to FY2025, as filed.

SGHTSight Sciences, Inc.

Healthcare

$8.46+144% 1Y

$8.46

$3.2052 weeks$9.34

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin widening (+29.9 points).

1 good, 1 neutral, 1 without data

Revenue trend+9% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +17% a year.

Margin direction+29.9 points operating

Trailing-twelve-month operating margin, -34.3% now against -64.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is SGHT growing?

Sight Sciences, Inc. has grown revenue 0.76% a year over three years and 17% a year over five.

+0.76%

Revenue growth, 3-year annual rate · Medical Devices median +12% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +17%
Revenue growth, 5-year rate · +0.76% over three · growth has slowed since the five-year average
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›